CLDN1 and lung cancer: For example, in lung cancer cells, claudin-1 is upregulated through activation of the PI3K/Akt/NF-κB pathway, decreasing permeability and resulting in inhibition of the penetration of anticancer drugs into the inner area of spheroids (110).